Your shopping cart is currently empty

Pelcitoclax (APG-1252) is a potent inhibitor of Bcl-2 and Bcl-xl proteins, demonstrating substantial antineoplastic and pro-apoptotic activities[1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $2,389 | 8-10 weeks | 8-10 weeks | |
| 10 mg | $3,819 | 8-10 weeks | 8-10 weeks | |
| 25 mg | $5,728 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $7,458 | 8-10 weeks | 8-10 weeks |
| Description | Pelcitoclax (APG-1252) is a potent inhibitor of Bcl-2 and Bcl-xl proteins, demonstrating substantial antineoplastic and pro-apoptotic activities[1]. |
| In vitro | APG-1252 undergoes metabolic transformation into its reactive form, APG-1252-M1, which exhibits significant antitumor activity in (acute myeloid leukemia)[1]. |
| In vivo | Pelcitoclax (APG-1252; 25-100 mg/kg; i.v.; once daily for 10 days) treatment shows significantly greater inhibition of xenograft tumor growth compared to other groups[1]. |
| Molecular Weight | 1281.84 |
| Formula | C57H66ClF4N6O11PS4 |
| Cas No. | 1619923-36-2 |
| Smiles | CC(C)n1c(C)c(c(c1-c1ccc(Cl)cc1)-c1cc(F)cc(c1)N1CCN(CC1)c1ccc(NS(=O)(=O)c2ccc(N[C@H](CCN3CCC(CC3)C(=O)OCCCP(O)(O)=O)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)cc1)S(C)(=O)=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.